High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia

被引:11
|
作者
Aly, Rabab M. [1 ]
Ghazy, Hayam F. [2 ]
机构
[1] Mansoura Univ, Fac Med, Dept Clin Pathol, Mansoura, Egypt
[2] Mansoura Univ, Fac Med, Dept Internal Med, Med Oncol Unit, Mansoura, Egypt
关键词
Prognosis; GRAF; AML; Focal adhesion; SIGNAL-TRANSDUCTION; RHO; CANCER; GENE; TRANSFORMATION; PROTEIN; RAS;
D O I
10.1016/j.bcmd.2014.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: GRAF is a recognized tumor suppressor gene that was found inactivated in AML. However, the prognostic role of a GRAF transcript has not been studied in patients with AML. Methods: In this study, we investigated the expression of the GRAF transcript by real time quantitative PCR in 60 AML patients and 30 healthy age and sex matched controls. Results: GRAF expression was significantly lower in patients with AML when compared to controls (P = 0.008). There were no significant differences in clinical features, FAB subtypes and cytogenetic risk subgroups between patients with high and low GRAF expression levels. Kaplan-Meier analysis showed that patients with high GRAF expression had longer overall survival (OS). Multivariate analysis revealed that, besides WBC count, GRAF expression was also an independent prognostic factor for AML. Conclusion: We provide evidence that high GRAF expression is a favorable prognostic marker in patients with AML. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 50 条
  • [31] High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia
    Ren, Zhihong
    Huang, Xiaoyu
    Lv, Qing
    Lei, Yiming
    Shi, Haiqiang
    Wang, Fanping
    Wang, Mingyong
    FRONTIERS IN GENETICS, 2022, 13
  • [32] High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia
    Tang, Ruoping
    Hirsch, Pierre
    Fava, Fanny
    Lapusan, Simona
    Marzac, Christophe
    Teyssandier, Irene
    Pardo, Julia
    Marie, Jean-Pierre
    Legrand, Ollivier
    BLOOD, 2009, 114 (14) : 2993 - 3000
  • [33] High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia
    Ma, Qiu-Ling
    Wang, Jing-Han
    Wang, Yun-Gui
    Hu, Chao
    Mu, Qi-Tian
    Yu, Meng-Xia
    Wang, Lei
    Wang, Dong-Mei
    Yang, Min
    Yin, Xiu-Feng
    Chen, Fei-Fei
    Lu, Sha-Sha
    Chen, Jian
    Zhu, Zhi-Juan
    Chen, Sai-Juan
    Jin, Jie
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1058 - 1065
  • [34] Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia
    Thomas, X
    Campos, L
    Mounier, C
    Cornillon, J
    Flandrin, P
    Le, QH
    Piselli, S
    Guyotat, D
    LEUKEMIA RESEARCH, 2005, 29 (09) : 1049 - 1058
  • [35] High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia
    Du, Wen
    He, Jing
    Zhou, Wei
    Shu, Simin
    Li, Juan
    Liu, Wei
    Deng, Yun
    Lu, Cong
    Lin, Shengyan
    Ma, Yaokun
    He, Yanli
    Zheng, Jine
    Zhu, Jiang
    Bai, Lijuan
    Li, Xiaoqing
    Yao, Junxia
    Hu, Dan
    Gu, Shengqing
    Li, Huiyu
    Guo, Anyuan
    Huang, Shiang
    Feng, Xiaolan
    Hu, Dong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [36] High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions
    Hout, Florentien E. M. in't
    van der Reijden, Bert A.
    Monteferrario, Davide
    Jansen, Joop H.
    Huls, Gerwin
    HAEMATOLOGICA, 2014, 99 (12)
  • [37] Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor
    Weng, Ping
    Yang, Shu
    Xu, Shujuan
    Zhang, Shuxia
    Wu, Yong
    Chen, Yuanzhong
    HEMATOLOGY, 2023, 28 (01)
  • [38] The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
    Diaz-Beya, M.
    Brunet, S.
    Nomdedeu, J.
    Cordeiro, A.
    Tormo, M.
    Escoda, L.
    Ribera, J. M.
    Arnan, M.
    Heras, I.
    Gallardo, D.
    Bargay, J.
    Queipo de Llano, M. P.
    Salamero, O.
    Marti, J. M.
    Sampol, A.
    Pedro, C.
    Hoyos, M.
    Pratcorona, M.
    Castellano, J. J.
    Nomdedeu, M.
    Risueno, R. M.
    Sierra, J.
    Monzo, M.
    Navarro, A.
    Esteve, J.
    BLOOD CANCER JOURNAL, 2015, 5 : e352 - e352
  • [39] High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics
    He, Xue
    Hu, Jing
    Yan, Changjian
    Liu, Xiaoni
    Zhao, Yali
    Yang, Ping
    Wang, Jing
    Li, Shaoxiang
    Zhang, Wei
    Dong, Gehong
    Zhang, Weilong
    Jing, Hongmei
    CANCER BIOMARKERS, 2023, 36 (03) : 221 - 230
  • [40] CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia
    Haferlach, Claudia
    Bacher, Ulrike
    Kohlmann, Alexander
    Schindela, Sonja
    Alpermann, Tamara
    Kern, Wolfgang
    Schnittger, Susanne
    Haferlach, Torsten
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (06): : 829 - 836